Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1165311 | 0.85 | ALDH1A1 (0.33) | LMNAALDH1A1CHRNA1CHRNB2CHRNA3 | |
| SCHEMBL1165139 | 0.84 | CYP11B1 (0.33) | — | |
| SCHEMBL29728033 | 0.84 | ALDH1A1 (0.37) | LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL119406 | 0.84 | ALDH1A1 (0.37) | LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL1165093 | 0.84 | NPC1 (0.33) | ALDH1A1CHRNA1CHRNB2CHRNA3CHRNA7 | |
| SCHEMBL1165522 | 0.82 | ALDH1A1 (0.34) | ALDH1A1CHRNA1CHRNB2CHRNA3CHRNA7 | |
| SCHEMBL1165038 | 0.81 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL1165136 | 0.80 | CHRNA1 (0.32) | L3MBTL1CHRNA1CHRNB2CHRNA3CHRNA7 | |
| SCHEMBL1165144 | 0.80 | CHRNA1 (0.32) | L3MBTL1CHRNA1CHRNB2CHRNA3CHRNA7 | |
| SCHEMBL1165000 | 0.79 | CHRNA1 (0.31) | CHRNA1CHRNB2CHRNA3CHRNA7CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110039894-A1 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2011-02-17 | — | — | US | claimed |
| EP-2107058-A1 | Substituted enaminothiocarbonyl compounds | Bayer CropScience AG (DE) | 2009-10-07 | — | — | EP | claimed |
| US-8563584-B2 | Substituted enaminothiocarbonyl compounds | BAYER CROPSCIENCE AG (DE) | 2013-10-22 | — | — | US | disclosed |
| US-20110039894-A1 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2011-02-17 | — | — | US | disclosed |
| WO-2009121507-A2 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2009-10-08 | — | — | WO | disclosed |
| EP-2107058-A1 | Substituted enaminothiocarbonyl compounds | Bayer CropScience AG (DE) | 2009-10-07 | — | — | EP | disclosed |
| EP-2107058-A1 | Substituted enaminothiocarbonyl compounds | Bayer CropScience AG (DE) | 2009-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110039894-A1 | SUBSTITUTED ENAMINOTHIOCARBONYL COMPOUNDS | DDT, PTMS, AADAC | LMNA 2135/4885L3MBTL1 23/4885ALDH1A1 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.